CBI probes alleged bribery linked to CDSCO regulatory clearances

The Central Bureau of Investigation has registered a case involving a CDSCO official and a pharma executive over alleged bribery linked to regulatory clearances. The investigation may lead to increased scrutiny of interactions between regulatory officials and applicants during the processing of drug-related clearances.

Join our 1500+ subscribers to get our daily Health Laws and Policy Updates.